Welcome to LookChem.com Sign In|Join Free

CAS

  • or

17044-70-1

Post Buying Request

17044-70-1 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

17044-70-1 Usage

Preparation

Preparation by Fries rearrangement of 2,6-dichlorophenyl acetate with aluminium chloride without solvent at 140–150°.

Check Digit Verification of cas no

The CAS Registry Mumber 17044-70-1 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,7,0,4 and 4 respectively; the second part has 2 digits, 7 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 17044-70:
(7*1)+(6*7)+(5*0)+(4*4)+(3*4)+(2*7)+(1*0)=91
91 % 10 = 1
So 17044-70-1 is a valid CAS Registry Number.
InChI:InChI=1/C8H6Cl2O2/c1-4(11)5-2-6(9)8(12)7(10)3-5/h2-3,12H,1H3

17044-70-1Relevant articles and documents

A general strategy to optimize the performance of aza-BODIPY-based probes for enhanced photoacoustic properties

Yadav, Anuj K.,Tapia Hernandez, Rodrigo,Chan, Jefferson

, p. 415 - 441 (2021/07/26)

In this chapter, we describe a generalizable strategy to obtain a high PA output platform that is optimized for ratiometric imaging. Our approach entails conformationally restricting pendant aryl rings on the aza-BODIPY core to enhance orbital overlap which consequently increases the extinction coefficient. This strategy can potentially be applied to other dye platforms to enhance their signal intensity. We provide detailed protocols for the synthesis, in vitro characterization, and in vivo application.

BETA-HYDROXYETHYLAMINES FOR USE IN THE TREATMENT OR PREVENTION OF NON-ALCOHOLIC FATTY LIVER DISEASES

-

, (2019/04/11)

There is herein provided a compound of formula (I) or a pharmaceutically acceptable salt thereof, for use in the treatment of a non-alcoholic fatty liver disease (NAFLD), such as non-alcoholic steatohepatitis (NASH), wherein X, R1, R2, R3 and n have meanings as provided in the description.

COMPOUNDS FOR THE TREATMENT OF HYPERGLYCAEMIA

-

, (2017/09/28)

There is herein provided a compound of formula (I) or a pharmaceutically acceptable salt thereof, for use in the treatment of hyperglycaemia or a disorder characterized by hyperglycaemia, such as type 2 diabetes, wherein X, R1, R2, R3 and n have meanings as provided in the description.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 17044-70-1